Our aim was to investigate the effect of platelet-rich plasma (PRP) derivatives, which 30 can be produced from the patient's own blood and have minimal side effects, on 31 endometriosis. To the best of our knowledge, this is the first study in the literature that studies 32 the relationship between PRP and endometriosis. Endometriosis foci were created in the first 33 operation. In the second operation (30 th day) groups were formed. Group 1 (n= 8) was 34 administered saline, group 2 (n= 7) leukocyte-and platelet-rich plasma (L-PRP), and group 3 35 (n= 8) pure platelet-rich plasma (P-PRP). Group 4 (n= 10) was used to obtain PRP. In the last 36 operation (60 th day), the endometriotic foci were measured, and then excised. There was no 37 statistically significant difference between the pre and post volumes of the endometriotic foci, 38 between their volume differences and volume difference rates (p > .05). However, it was 39 observed that existing implant volumes in all groups decreased statistically significantly 40 within their own groups by the end of the experiment compared to the previous volumes (p < 41 .05). When the implants were assessed through histopathological scoring in terms of edema, 42 vascular congestion, inflammatory cell infiltration, hemorrhage, epithelial line, and 43 hemosiderin accumulation and immunohistochemical staining in terms of VEGF, there was 44 no significant difference in the comparison between the groups. Although L-PRP and P-PRP 45 generated more reduction in the endometriosis foci, they did not create any statistical 46 differences.
Introduction
Preparation of PRPs 138 Ten additional rats were used to obtain blood for PRP. These rats (n= 24) were 139 administered 10% ketamine (80 mg/ kg Ketalar; Eczacibasi, Istanbul, Turkey) and 2% 140 xylazine chloride (15 mg/ kg, Rompun; Bayer Health Care LCC, Kansas, KS) 141 intraperitoneally for anesthesia, and their blood samples were drawn through cardiac 142 puncture. The blood was anticoagulated using acid-citrate dextrose solution A (ACD-a) at a 143 rate of 1/9. A total of 38-40 cc PRP (L-PRP and P-PRP) was obtained from the 10 rats.
144
Preparation of L-PRP 145 L-PRP was prepared using the double centrifuge method based on buffy coat. The 146 whole blood from five rats was centrifuged at room temperature for 10 minutes at 250 g, and 7 147 it was ensured that the blood was separated into three layers: Erythrocytes at the bottom, 148 buffy coat in the middle (rich in platelets, leukocytes and fibrinogen), and plasma containing 149 platelets at the top. The platelets-containing plasma and buffy coat were later transferred into 150 a new tube. A large portion of the platelets, leukocytes, and fibrinogen was re-centrifuged for 151 10 minutes at 1000 g to form precipitate. The supernatant plasma was thrown away, and the 152 precipitated platelets were re-suspended in the residue plasma to obtain L-PRP 25, 26 .
153 Preparation of P-PRP 154 P-PRP is a plasma-based method that concentrates platelets and eliminates leukocytes 155 and erythrocytes. The anticoagulated whole blood that was drawn from the five rats was 156 centrifuged at room temperature for 10 minutes at 160 g to separate platelets-containing 157 plasma (rich in leukocytes) from erythrocytes and the buffy coat. Attention was paid to 158 prevent the buffy coat and erythrocyte contamination. The platelets-containing plasma was 159 then transferred to a new tube and centrifuged for 15 minutes at 250 g. The supernatant 160 plasma was thrown away, and the precipitated platelets were re-suspended in the residue 161 plasma to obtain L-PRP 25,26 .
162
Histopathological examination 163 All pathological examinations were blindly carried out by a single expert (K.A.).
164
Biopsies were fixated for 24 hours in 10% formaldehyde. Paraffin blocks were created, and 165 the blocks were cut in thickness of 5 um. A total of 5 sections were obtained for each 166 material, stained with hematoxylin eosin (HE) and assessed with a light microscope. Edema, 167 vascular congestion, inflammatory cell infiltration, fresh hemorrhage and hemosiderin 168 formations were noted (scoring 0-3 where 0= None, 1= Light, 2= Medium, 3= Heavy).
169
Histopathological diagnosis was determined by the recognition of endometrial tissue, gland 170 and stroma, and by the determination of endometrial lining and luminal formation. The 171 presence of endometrial cells in autografts was assessed semi-quantitatively. The pathological 8 172 evaluation of the uterine autografts was carried out as described in an earlier method -A 173 well-preserved epithelial line= 3 points, a moderately preserved epithelium with leukocyte 174 infiltration= 2 points, a poor epithelium with rare epithelial cells= 1 point, and no epithelium= 175 0 points 24 (Fig 2) . 
Results

205
Three groups were formed in the study -Group 1: Control, Group 2: L-PRP, and 206 Group 3: P-PRP. It was confirmed by the pathologist that the foci were histopathologically 207 endometriosis in all groups. Among the groups, the pre and post volumes of the endometriotic 208 foci created, volume differences between them and volume difference rates between them are 209 seen in Table 1 . Considering this table, there is no statistically significant difference between 210 the groups (p > .05). However, it was observed that existing implant volumes in all groups 211 decreased statistically significantly within their own groups by the end of the experiment 212 compared to the previous volumes (p < .05) (Fig 3) . When the implants were assessed through 213 histopathological scoring in terms of edema, vascular congestion, inflammatory cell 214 infiltration, and fresh hemorrhage, there was no significant difference in the comparison 215 between the groups in terms of the total score that was obtained ( Table 1) . where estrogen was not used, the volume after the treatment was significantly less compared 261 to the control group in resveratrol and leuprolide acetate groups 10 . We also found in our study,
216
262
where we did not administer estrogen, that implant volumes in PRP groups were significantly 263 decreased after the treatment (p < .05). However, this significant decline was similarly present 264 in the control group, and the rate of volume change did not show any significant difference 265 between the groups (Table 1 ).
266
Another parameter that is compared in endometriosis studies is the histopathological 267 evaluation of the endometrial glandular and stromal structures that are carried out semi-268 quantitatively. In a number of studies, there have been significantly lower values compared to 269 the control group after various treatments, while in some others, there have been no 270 significant changes 10,24,32 . We did not observe any significant differences in the post-treatment 271 groups in which we carried out epithelial assessments similar to the studies in the literature 13 272 (Table 2) . However, the point is that in the L-PRP group, the epithelial score was 0. There 273 were no cells. L-PRP had almost destroyed the endometrial foci. Nevertheless, this 274 circumstance had not been reflected in the accumulation of hemosiderin. It was similar in 275 every group (Table 2) . Hemosiderin is a significant indicator in the assessment of 276 endometriosis 33,34 . In other words, it seems that the endometrial focus examination should not 277 be carried out based on a single factor. We also assessed the inflammatory changes in 278 histopathological scoring as a total score in our study but did not observe any differences 279 between the groups (Table 1) .
280
While there are many studies of PRP, which includes several growth factors, in different shown to reduce endometriosis and cause decreased levels of VEGF in foci 45, 46 . Although it 299 has been shown that VEGF levels increase in the tissue with PRP treatment, there are also 300 studies that show that there is no increase and that the treatment does not cause any 301 difference 47-49 . We did not see any significant difference between the VEGF levels in the post-302 treatment implants in our study, either ( In our study, PRP derivatives were applied on the implant once in the form of an 321 injection. Perhaps the application of the injections into the implant or intravenously, or 15 322 simultaneously application of them with repeated doses at certain intervals could result in 323 different and effective results. We can think of a limitation of our study that we did not 324 histopathologically examine the similar implants in the first month in which the foci were 325 found to have been formed. They have not been examined in many studies, either. We also 326 performed an endometrial implantation, as in most past studies 22,23 . To the best of our 327 knowledge, our current study is the first study of the relationship between PRP and 328 endometriosis, which can be considered as a preliminary study. Although our results were not 329 significant, it was promising that the PRP foci did not grow, and they did not stay the same -330 they shrank. Therefore, in order to investigate the effect of PRP, which has many important 331 features, on endometriosis, there is a need for larger research studies which have different 332 applications with different doses.
333
Conclusion
334
In conclusion, the endometriosis foci were shrinking over time. This reduction was 335 observed in all groups and was significant. However, the shrinking of endometriosis foci did 336 not show any statistically significant difference among the groups. Moreover, there was no 337 difference between the groups in terms of epithelial score, hemosiderin deposits, VEGF and 338 total score. In other words, although both L-PRP and P-PRP generated more reduction in the 339 endometriosis foci, they did not create any statistical differences. 
